Pharmacogenomics : social, ethical, and clinical dimensions

摘要: Foreword (F. Collins). Preface. PART I: INTRODUCTION: SCIENCE AND SOCIETY. Public Attitudes About Pharmacogenomics (M. Rothstein, et al.). Pharmacogenomics: Pharmacology and Toxicology in the Genomics (H. Mohrenweiser). The Implications of Population Genetics for (C. Hanis). II: RESEARCH DEVELOPMENT CHALLENGES CONSIDERATIONS. Genome Research Minorities Greely). Drug Development Strategies (P. Manasco & T. Arledge). Development, Regulation, Genetically Guided Therapy (D. Feigal S. Gutman). Intellectual Property Commercial Aspects (A. Nunnally, III: CLINICAL APPLICATIONS. Integration into Medical Practice (G. Omenn A. Motulsky). Clinical Utility Pharmacogenetics (N. Holtzman). Liability (L. Palmer). Challenges Pharmacy Education, Practice, Regulation Brushwood). IV: THE SOCIAL DIMENSION. Economic Reeder W. Dickson). Social Construction Identity Foster). Considerations Communities Color Nsiah-Jefferson). Constitutional Issues Use Pharmacogenomic Variations Associated with Race (J. Robertson). V: EPILOGUE: POLICY PRESCRIPTIONS Rothstein). Minority Populations: General Survey Questionnaire Index.